首页> 外文期刊>European spine journal >Routine needle biopsy during vertebral augmentation procedures. Is it necessary?
【24h】

Routine needle biopsy during vertebral augmentation procedures. Is it necessary?

机译:椎体隆突过程中的常规穿刺活检。有必要吗?

获取原文
           

摘要

Vertebral augmentation procedures are currently widely performed to treat vertebral compression fractures. The purpose of this study was to determine the frequency of underlying previously unrecognized etiology in a consecutive series of patients undergoing kyphoplasty to treat vertebral compression fractures. A prospective histological evaluation of vertebral body biopsy specimens from presumed osteoporotic vertebral compression fractures were performed in order to identify aforementioned causes. Over a 2-year period, vertebral body biopsies from 154 vertebral levels were performed in 75 patients undergoing kyphoplasty for vertebral compression fractures. All patients received a preoperative workup that included plain radiographs, MRI, whole body bone scan, and laboratory examinations. Bone specimens were obtained from affected vertebral bodies and submitted for histologic evaluation to identify the prevalence of an underlying cause. All specimens demonstrated fragmented bone with variable amounts of unmineralised bone, signs of bone-remodeling and/or fracture-healing. In 11 patients underlying pathology other than osteoporosis was identified (prostate cancer, 1; pancreatic cancer, 1; colon cancer, 1; breast cancer, 2; multiple myeloma, 3; leukemia, 1; and lung cancer, 2). In all but one patient the results of the biopsy confirmed the diagnosis suspected from the preoperative workup. For the last patient, namely the one with pancreatic cancer, the workup did not identify the origin of the primary tumor, although the patient was considered to have a compression fracture secondary to metastatic disease of unknown origin, the vertebral biopsy suggested the presence of adenocarcinoma which eventually was proven to be pancreatic cancer. In augmentation procedures for vertebral compression fractures, bone biopsy should be reserved for the patients where the preoperative evaluation raises the suspicion of a non-osteoporotic etiology...
机译:目前广泛使用椎体增强手术来治疗椎骨压缩性骨折。这项研究的目的是确定连续一系列接受椎体后凸成形术治疗椎骨压缩性骨折的患者中先前无法识别的潜在病因的频率。为了确定上述原因,对来自假定的骨质疏松性椎体压缩性骨折的椎体活检标本进行了前瞻性组织学评估。在2年的时间里,对75名接受椎体后凸成形术治疗椎体压缩性骨折的患者进行了154次椎体水平的椎体活检。所有患者均接受了术前检查,包括平片,MRI,全身骨扫描和实验室检查。从患椎骨中获取骨标本,并进行组织学评估,以确定潜在原因的患病率。所有标本均显示碎骨,未矿化骨量不等,有骨重塑和/或骨折愈合的迹象。在11例患者中,发现了除骨质疏松症以外的其他病理类型(前列腺癌1例;胰腺癌1例;结肠癌1例;乳腺癌2例;多发性骨髓瘤3例;白血病1例;肺癌2例)。除一名患者外,在所有患者中,活检结果证实了术前检查中怀疑的诊断。对于最后一位患者,即胰腺癌患者,尽管该患者被认为患有继发于未知来源的转移性疾病的压迫性骨折,但检查并未确定原发性肿瘤的起源,椎骨活检提示存在腺癌。最终被证明是胰腺癌。在椎体压缩性骨折的增强手术中,应对术前评估引起怀疑为非骨质疏松病因的患者保留骨活检...

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号